Literature DB >> 9466565

Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.

A Messing1, M W Head, K Galles, E J Galbreath, J E Goldman, M Brenner.   

Abstract

Increased expression of glial fibrillary acidic protein (GFAP) is a hallmark of gliosis, the astrocytic hypertrophy that occurs during a wide variety of diseases of the central nervous system. To determine whether this increase in GFAP expression per se alters astrocyte function, we generated transgenic mice that carry copies of the human GFAP gene driven by its own promoter. Astrocytes of these mice are hypertrophic, up-regulate small heat-shock proteins, and contain inclusion bodies identical histologically and antigenically to the Rosenthal fibers of Alexander's disease. Mice in the highest expressing lines die by the second postnatal week. The results support the notion that Alexander's disease is a disorder of astrocytes, and provide an animal model for studying the causes and consequences of inclusion body disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466565      PMCID: PMC1857948     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

1.  Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology.

Authors:  M A McCall; R G Gregg; R R Behringer; M Brenner; C L Delaney; E J Galbreath; C L Zhang; R A Pearce; S Y Chiu; A Messing
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

Review 2.  Pathology and biology of the Lewy body.

Authors:  M S Pollanen; D W Dickson; C Bergeron
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

3.  Alpha B-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain.

Authors:  T Iwaki; A Kume-Iwaki; R K Liem; J E Goldman
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

4.  Characterization of human cDNA and genomic clones for glial fibrillary acidic protein.

Authors:  M Brenner; K Lampel; Y Nakatani; J Mill; C Banner; K Mearow; M Dohadwala; R Lipsky; E Freese
Journal:  Brain Res Mol Brain Res       Date:  1990-05

5.  GFAP Transgenic Mice

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

6.  Quantification of glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA.

Authors:  J P O'Callaghan
Journal:  Neurotoxicol Teratol       Date:  1991 May-Jun       Impact factor: 3.763

7.  Overexpression and abnormal modification of the stress proteins alpha B-crystallin and HSP27 in Alexander disease.

Authors:  M W Head; E Corbin; J E Goldman
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

8.  Synthesis and turnover of cytoskeletal proteins in cultured astrocytes.

Authors:  F C Chiu; J E Goldman
Journal:  J Neurochem       Date:  1984-01       Impact factor: 5.372

9.  Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons.

Authors:  D E Weinstein; M L Shelanski; R K Liem
Journal:  J Cell Biol       Date:  1991-03       Impact factor: 10.539

Review 10.  Molecular profile of reactive astrocytes--implications for their role in neurologic disease.

Authors:  M Eddleston; L Mucke
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

View more
  83 in total

1.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

Review 2.  The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Authors:  Pietro Balbi; Silvana Salvini; Cira Fundarò; Giuseppe Frazzitta; Roberto Maestri; Dibo Mosah; Carla Uggetti; GianPietro Sechi
Journal:  J Neurol       Date:  2010-08-20       Impact factor: 4.849

Review 3.  Neuropathology for the neuroradiologist: Rosenthal fibers.

Authors:  F J Wippold; A Perry; J Lennerz
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  Transcriptional repression and cell death induced by nuclear aggregates of non-polyglutamine protein.

Authors:  Lianwu Fu; Ya-sheng Gao; Elizabeth Sztul
Journal:  Neurobiol Dis       Date:  2005-06-16       Impact factor: 5.996

5.  Nigella sativa Oil Reduces Extrapyramidal Symptoms (EPS)-Like Behavior in Haloperidol-Treated Rats.

Authors:  Tafheem Malik; Sheema Hasan; Shahid Pervez; Tasneem Fatima; Darakhshan Jabeen Haleem
Journal:  Neurochem Res       Date:  2016-10-18       Impact factor: 3.996

6.  GFAP Mutations in Astrocytes Impair Oligodendrocyte Progenitor Proliferation and Myelination in an hiPSC Model of Alexander Disease.

Authors:  Li Li; E Tian; Xianwei Chen; Jianfei Chao; Jeremy Klein; Qiuhao Qu; Guihua Sun; Guoqiang Sun; Yanzhou Huang; Charles D Warden; Peng Ye; Lizhao Feng; Xinqiang Li; Qi Cui; Abdullah Sultan; Panagiotis Douvaras; Valentina Fossati; Neville E Sanjana; Arthur D Riggs; Yanhong Shi
Journal:  Cell Stem Cell       Date:  2018-08-02       Impact factor: 24.633

7.  Properties of astrocytes cultured from GFAP over-expressing and GFAP mutant mice.

Authors:  Woosung Cho; Albee Messing
Journal:  Exp Cell Res       Date:  2008-12-29       Impact factor: 3.905

8.  Astrocytic TDP-43 pathology in Alexander disease.

Authors:  Adam K Walker; Christine M LaPash Daniels; James E Goldman; John Q Trojanowski; Virginia M-Y Lee; Albee Messing
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

9.  Can MR imaging diagnose adult-onset Alexander disease?

Authors:  L Farina; D Pareyson; L Minati; I Ceccherini; L Chiapparini; S Romano; P Gambaro; R Fancellu; M Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-03       Impact factor: 3.825

10.  Composition of Rosenthal Fibers, the Protein Aggregate Hallmark of Alexander Disease.

Authors:  Michael R Heaven; Daniel Flint; Shan M Randall; Alexander A Sosunov; Landon Wilson; Stephen Barnes; James E Goldman; David C Muddiman; Michael Brenner
Journal:  J Proteome Res       Date:  2016-06-02       Impact factor: 4.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.